CTE Can Cause Dementia, According to New Boston University Study
BU CTE Center researchers found advanced stage of the progressive brain disease increases odds of dementia fourfold.
A Solution to the Cocktail Party Problem—Hidden in the Brain
BU researchers are mixing neuroscience, photonics, and engineering to help people with hearing loss pick out sounds in noisy spaces.
Brink Bites: BU Expert to Help Lead UN Climate Report, Undergraduates Study Secrets of the Universe
The Brink’s latest collection of news nuggets, short stories, and other thought-provoking snippets from the world of Boston University research—including a BU expert being tapped to help lead a major United Nations climate report.
Best of The Brink 2025: 10 Inspiring Inventions and Impactful Ideas from Boston University Researchers
From soft robots that could make cancer surgery safer to an algorithm that boosts hearing aid performance, how BU research made a difference this year.
BU Neuroscientist’s “Riveting Debut” Book Discusses “How to Change a Memory”
Steve Ramirez draws on research and his own life for insights into the science of remembering, including creating false memories.
Brink Bites: BU Health Researchers Win Major NIH Grants; BU Device Named Among Time’s Best Inventions of 2025
Other research news, stories, and tidbits from around BU, including big funding wins, opposition to deepfakes, and studying LGBTQ+ suicide risk factors.
NIH Honors Two BU Researchers for Exceptionally Creative, High-Impact Science
The prestigious Director’s Awards will support work studying sexual health and stopping mosquito bites.
Why Do We Remember Some Life Moments—but Not Others?
BU study finds memories of mundane incidents can be strengthened when they get attached to a memory of an emotionally charged event.
BU CTE Center Study Ties Contact Sports Head Hits to Brain Damage
Repetitive head impacts can cause cell loss, inflammation, and vascular damage—even without CTE.
NIH Awards $15M to BU-Led Effort to Diagnose CTE During Life
New study to look for potential biomarkers of progressive brain disease; former NFL quarterback Matt Hasselbeck among the first to sign up.